The great rotation: Will short duration and cyclicality prosper in European markets?

Synchronised economic recovery

clock • 4 min read
John Surplice of Invesco

John Surplice of Invesco

On 9 November 2020, Pfizer and BioNTech announced that they had created an effective vaccine for Covid-19. This news drove a sharp rotation away from the so-called 'growth' and 'quality' sectors and into 'value' ones. In fact, it was one of the biggest rotations we had ever witnessed.

Ever since then investors appear to be grappling with the idea of whether or not this will be sustained or short-lived rotation. Four months have passed since the announcement and at the time of writing, 'value' as a factor has indeed outperformed 'growth' and 'quality' - though not in a straight line. It can be best described as a tug of war.  IW Long Reads: The commodities 'supercycle' - Is a climate change revolution fuelling optimism for markets? For us, as valuation focused investors, factors, in reality, do not matter that much. Yes, our European equity fund range continues t...

To continue reading this article...

Join Investment Week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now


Already an Investment Week


More on Europe

Daryl Liew, CIO at REYL Singapore.

REYL's Liew eyes return to overweight positions in Asian quality growth names

'It's a question of timing'

clock 28 June 2022 • 3 min read
The UK accounted for €4bn in net UCITS sales in April.

Monthly outflows persist across equity UCITS and AIFs in April

Improved from €42bn outflow in March

clock 27 June 2022 • 1 min read
Brian Raven, Tavistock chief executive

Tavistock revenues jump 14% amid year of acquisitions

Bought LEBC research firm

clock 27 June 2022 • 1 min read